Lanean...

Attacking malignant cells that survive therapy: Exploiting immunogenic modulation

We have recently defined “immunogenic modulation,” a mechanism whereby malignant cells that survive anticancer therapy, due to sublethal delivery or development of treatment resistance, become nonetheless more sensitive to killing by cytotoxic T lymphocytes. This mechanism can be exploited to identi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hodge, James W, Kwilas, Anna, Ardiani, Andressa, Gameiro, Sofia R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902115/
https://ncbi.nlm.nih.gov/pubmed/24498561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26937
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!